Skip to main content

Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.080 +0.010 (+0.33%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
February 28, 2016
Form 4
Source: SEC/Edgar
February 16, 2016
Form 4
Source: SEC/Edgar
February 10, 2016
Form 4
Source: SEC/Edgar
February 10, 2016
Form 4
Source: SEC/Edgar
February 09, 2016
Form 4
Source: SEC/Edgar
February 03, 2016
Form 4
Source: SEC/Edgar
January 31, 2016
Form 4
Source: SEC/Edgar
January 31, 2016
Form 4
Source: SEC/Edgar
January 07, 2016
Form 4
Source: SEC/Edgar
January 03, 2016
Form 4
Source: SEC/Edgar
January 03, 2016
Form 3
Source: SEC/Edgar
December 15, 2015
Form 4
Source: SEC/Edgar
December 15, 2015
Form 4
Source: SEC/Edgar
November 16, 2015
Form 4
Source: SEC/Edgar
September 03, 2015
Form 4
Source: SEC/Edgar
August 18, 2015
Form 4
Source: SEC/Edgar
July 20, 2015
Form 4
Source: SEC/Edgar
July 01, 2015
Form 4
Source: SEC/Edgar
July 01, 2015
Form 4
Source: SEC/Edgar
June 18, 2015
Form 4
Source: SEC/Edgar
June 04, 2015
Form 4/A
Source: SEC/Edgar
May 26, 2015
Form 4/A
Source: SEC/Edgar
May 26, 2015
Form 4
Source: SEC/Edgar
May 26, 2015
Form 4
Source: SEC/Edgar
May 20, 2015
Form 4
Source: SEC/Edgar
May 20, 2015
Form 4
Source: SEC/Edgar
May 20, 2015
Form 4
Source: SEC/Edgar
May 20, 2015
Form 4
Source: SEC/Edgar
May 18, 2015
Form 4
Source: SEC/Edgar
May 14, 2015
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.